RHÖN-KLINIKUM Aktiengesellschaft carries a market capitalization of 1.09B, placing it among publicly traded companies globally. Its enterprise value stands at -48.03M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.09B |
| Enterprise Value | -48.03M |
RHÖN-KLINIKUM Aktiengesellschaft currently has 66.94M shares outstanding.
| Shares Outstanding | 66.94M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
RHÖN-KLINIKUM Aktiengesellschaft trades at a trailing price-to-earnings ratio of 22.32. The price-to-sales ratio is 0.54, and the price-to-book ratio stands at 0.36.
| PE Ratio | 22.32 |
| PS Ratio | 0.54 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, RHÖN-KLINIKUM Aktiengesellschaft trades at an EV/EBITDA multiple of 18.98 and an EV/FCF ratio of 506.00. The EV/Sales ratio of 0.37 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.98 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.37 |
| EV / EBITDA | 18.98 |
| EV / EBIT | 18.98 |
| EV / FCF | 506.00 |
RHÖN-KLINIKUM Aktiengesellschaft maintains a current ratio of 2.63, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.63 |
| Quick Ratio | 1.61 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 13.70 |
RHÖN-KLINIKUM Aktiengesellschaft posts a return on equity of 3.20 and a return on invested capital of 2.38.
| Return on Equity (ROE) | 3.20 |
| Return on Assets (ROA) | 2.28 |
| Return on Invested Capital (ROIC) | 2.38 |
| Return on Capital Employed (ROCE) | 3.16 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 31.48 |
Over the trailing twelve months, RHÖN-KLINIKUM Aktiengesellschaft has paid 10.83M in income taxes, reflecting an effective tax rate of 19.73.
| Income Tax | 10.83M |
| Effective Tax Rate | 19.73 |
RHÖN-KLINIKUM Aktiengesellschaft's stock has gained approximately 10.71913% over the past 52 weeks. The 50-day moving average sits at 8.16, while the 200-day moving average is 8.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 10.71913% |
| 50-Day Moving Average | 8.16 |
| 200-Day Moving Average | 8.00 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, RHÖN-KLINIKUM Aktiengesellschaft generated 1.73B in revenue and converted that into 42.09M in net income, yielding earnings per share of 0.34. EBITDA reached 40.30M, while operating income came in at 40.30M.
| Revenue | 1.73B |
| Gross Profit | 483.89M |
| Operating Income | 40.30M |
| Pretax Income | 54.91M |
| Net Income | 42.09M |
| EBITDA | 40.30M |
| EBIT | 40.30M |
| Earnings Per Share (EPS) | 0.34 |
Total book value stands at 1.33B, with working capital of 562.01M providing operational flexibility.
| Cash & Cash Equivalents | 556.55M |
| Total Debt | N/A |
| Net Debt | -133.08M |
| Equity (Book Value) | 1.33B |
| Book Value Per Share | 19.86 |
| Working Capital | 562.01M |
RHÖN-KLINIKUM Aktiengesellschaft operates with a gross margin of 27.89, reflecting its pricing power and cost economics. The operating margin of 2.32 and net profit margin of 2.43 provide insight into operational efficiency.
| Gross Margin | 27.89 |
| Operating Margin | 2.32 |
| Pretax Margin | 3.17 |
| Profit Margin | 2.43 |
| EBITDA Margin | 2.32 |
RHÖN-KLINIKUM Aktiengesellschaft posts an Altman Z-Score of 2.15, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.15 |